Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
about
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical IntegrationMicrovascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediatorsMaternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaaPreeclampsia: a bioinformatics approach through protein-protein interaction networks analysis.In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis.2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practiceFull-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of PreeclampsiaPlacental growth factor influences maternal cardiovascular adaptation to pregnancy in mice.Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.miR455 is linked to hypoxia signaling and is deregulated in preeclampsia.Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat.Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complicationsSerum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patientsmiR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia.The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Angiogenesis in the placenta: the role of reactive oxygen species signalingStatistical regression model of standard and new laboratory markers and its usefulness in prediction of preeclampsia.Placenta-derived exosomes: potential biomarkers of preeclampsia.Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia.Effects of low molecular weight heparins and unfractionated heparin on viability of human umbilical vein endothelial cells.Contribution of angiotensinogen M235T and T174M gene variants and haplotypes to preeclampsia and its severity in (North African) Tunisians.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.Expression of Interferon γ by Decidual Cells and Natural Killer Cells at the Human Implantation Site: Implications for Preeclampsia, Spontaneous Abortion, and Intrauterine Growth Restriction.Supplementing punicalagin reduces oxidative stress markers and restores angiogenic balance in a rat model of pregnancy-induced hypertension.
P2860
Q26796661-086D7F3A-28F2-4851-B961-E26E4A762314Q33612318-22A1D57A-6127-4F3D-9845-9BC7D03459B1Q33863973-247371A9-EFD7-47C3-80ED-27034A265C4EQ34182374-457F500B-1802-490E-B818-6C2C3185BC49Q34370899-5AE4950D-3EA9-4F49-BAB1-8C572D4B0994Q34505704-C02E4B5E-7A83-4EA5-8793-C5F4E4F4C913Q34544386-535ABDDE-3E90-49CF-A8AA-F63DE987BB7AQ34619975-6C7679AB-5343-4405-82CC-1E16DF19C9BEQ34852364-84975B35-00F3-4168-B02C-087435AE5E49Q34876226-BB4E04CD-7914-408A-97C8-CC5C80A64BB0Q35204444-DF0AE59D-28D3-418D-8240-27F17074F1ECQ35362708-19EF3F7E-C299-4E23-90F8-73BC12EE7DC9Q35813842-E353F831-7720-4DA0-8C37-0340710F5E5DQ35815335-EFFAE120-59F0-4239-9E0F-7F29A047FC6CQ35923222-81906162-B509-43B5-84E0-D5804FBF56A2Q35966243-DA7D2EBA-3153-4CBF-B024-F853271155F4Q36486994-92CA1ECE-AAB6-4B7F-BAD6-8943C28CB807Q36667589-01A830AD-1CD0-4FE0-8D40-13AB0F436E3AQ37206251-DBAD3C78-9C1F-49D6-AA12-817057FE92E3Q37271482-2F4282FC-F9E3-46EC-A8D5-7B42BA2CE79DQ38176651-09C75C06-7468-4228-8D6F-FD6ED8C18456Q38594110-E308935E-D7DA-47B9-9729-87ECD09E5330Q39376655-26BCE1DE-0B93-420F-9A2E-30226E7FB905Q41033848-570B9C3F-C1E0-4DC9-8E78-10A05CA0F013Q41839328-D86DBD87-C4DC-498D-AA79-4CC00E21900AQ44652577-2A64555B-8E5E-4946-9119-BBBAD3A5C08EQ45035228-AC90F4E9-F1D1-4BF2-B1CF-D43278CBB96EQ46305857-4CE4A256-4557-478E-9272-9D53CA1D0591Q46317860-3E9F90A5-14DC-4195-9725-DDD472CF4753Q47284780-9B3F0F5B-5AC0-4DD8-9B87-BD37FA0BC315Q47546219-1A9B6A29-2AB4-489C-8BCB-66BDDA7B142DQ49312791-60CF6409-6364-4771-B0AD-9C917D838C79Q50000298-CDDB91DF-48F3-44CA-A9B1-43EB4A80BFB7Q51008525-C2787FD3-BB9F-4400-9E21-AB9CC0A4B240Q54161406-2A4AD3C0-27D3-4E26-8B7A-4FDB3697C711Q54990701-7584E8C1-AE22-4B62-AAAA-70F02EEB0194Q55270146-5FADD7CA-9155-4AEB-8A90-CA29B247219BQ55378382-466C035B-197B-477B-AD9E-37F8053F5179
P2860
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@en
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@nl
type
label
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@en
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@nl
prefLabel
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@en
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@nl
P2860
P921
P356
P1433
P1476
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
@en
P2093
Holger Stepan
P2860
P356
10.1042/CS20110097
P407
P577
2012-01-01T00:00:00Z